Payami, Babak, Afshin Zarrin, Mofid Hosseinzadeh, Habib Haybar, and Sepideh Khodamoradi. “Amiodarone Can Still Be a Drug of Choice at Emergency Departments for Pre-Excited Atrial Fibrillation Even in the Face of Guidelines Prohibition”. Iranian Journal of Emergency Medicine 10, no. 1 (May 2, 2023): e8. Accessed March 3, 2024. https://journals.sbmu.ac.ir/iranjem/article/view/40732.